News & Analysis as of

Healthcare Reform › Biden Administration › Federal Funding

Bond Schoeneck & King PLLC

Destabilizing Federal Medicaid Proposals Dangle Like Damocles’s Sword Over New York’s Health Care System

Bond Schoeneck & King PLLC on

New York State’s FY '26 budget is balancing precariously on a banana peel. Although Governor Hochul finally approved the budget in May after a weekslong standoff with the legislature, the budget rests on assumptions that...more

Epstein Becker & Green

Breaking Down the Shifting Vaccine Policy Landscape – Diagnosing Health Care Video Podcast

Epstein Becker & Green on

Important changes are unfolding in the vaccine space. How have vaccine exemptions posed a significant risk to populations across the country? What are the long-lasting effects of the new administration's federal health...more

Sheppard Mullin Richter & Hampton LLP

Medicaid in the Crosshairs What Restructuring Could Mean for States, Providers, and Beneficiaries

Sheppard Mullin Richter & Hampton LLP on

As budget negotiations heat up in Washington, Medicaid has emerged as a key target for cost-cutting measures. With policymakers looking to trim federal spending while maintaining commitments to Social Security and Medicare,...more

Holland & Knight LLP

Holland & Knight Health Dose: February 11, 2025

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

McDermott+

Healthcare Preview for the Week of: March 11, 2024

McDermott+ on

BIDEN’S BUDGET - Today, Monday, March 11, President Biden released his budget for fiscal year (FY) 2025. While the budget request represents the administration’s funding goals for the coming year, it also sheds light on...more

Sterne, Kessler, Goldstein & Fox P.L.L.C.

IP Hot Topic: Biden Administration Proposes Framework for Exercising Bayh-Dole March-in Rights to Control Drug Pricing

Sterne, Kessler, Goldstein & Fox P.L.L.C. on

The Biden-Harris Administration recently announced various actions to lower healthcare and prescription drug costs. In one action, the National Institute of Standards and Technology (NIST) released in December 2023 a draft...more

McDermott+

Healthcare Preview for the Week of: January 22, 2024

McDermott+ on

CONGRESS BUYS MORE TIME - Last Friday President Biden signed a short-term funding patch. This extends government funding through a continuing resolution (CR) into March. Specifically, this CR gives Congress until March 1...more

Polsinelli

Fall Congressional Forecast: Eye on Federal Funding and Health Care

Polsinelli on

Congress faces a crowded agenda this fall comprised of must-pass policy initiatives and potential political messaging opportunities in the lead up to the November midterm elections. With control of both chambers at stake, the...more

Stinson LLP

The Impact of the New Inflation Reduction Act on Infrastructure Initiatives

Stinson LLP on

Congress has injected yet another wave of stimulus funding as the Biden Administration attempts to shape the future of America’s infrastructure. On August 16, 2022, President Biden signed into law House Bill 5376, known as...more

Morgan Lewis

What the Future May Hold for Pharma Regulation Under the Biden Administration

Morgan Lewis on

Under President Joe Biden, pharmaceutical regulation may see increased FDA guidance, new strategies to speed up innovation and regulatory review, and a renewed focus on diseases with unmet needs, among other expectations....more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide